Sustaining Remission of Psychotic Depression

ClinicalTrials.gov ID: NCT01427608

Public ClinicalTrials.gov record NCT01427608. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

View official ClinicalTrials.gov record → Back to search

ClinicalTrials.gov public records Last synced Jul 21, 2026, 4:42 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Study identification

NCT ID: NCT01427608
Recruitment status: Completed
Study type: Interventional
Phase: Phase 4
Lead sponsor: Weill Medical College of Cornell University; Other
Enrollment: 269 participants

Conditions and interventions

Conditions

Psychotic Depression

Interventions

Sertraline + Olanzapine Drug
Sertraline + Placebo Drug

Drug

Eligibility (public fields only)

Age range: 18 Years to 85 Years
Sex: All
Healthy volunteers: Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date: Sep 30, 2011
Primary completion: Nov 29, 2017
Completion: Nov 29, 2017
Last update posted: Mar 4, 2019

2011 – 2017

United States locations

U.S. sites: 3
U.S. states: 3
U.S. cities: 3

Facility	City	State	ZIP	Site status
Anthony Rothschild, MD	Worcester	Massachusetts	01605	—
George Alexopoulos, MD	White Plains	New York	10605	—
Ellen Whyte, MD	Pittsburgh	Pennsylvania	15213	—

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 1 non-U.S. site.

About this trial record page

What this page shows: Public field values for ClinicalTrials.gov record NCT01427608, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do: No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from: Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh: Last update posted Mar 4, 2019 · Synced Jul 21, 2026

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT01427608 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →